People · Operator
Named in public records as an officer, director or promoter · active 2008–2022 · Biotechnology, Manufacturing, Other Technology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Selexys Pharmaceuticals Corp | — | Biotechnology | Series C | $89.1M | $1.8B | 2008 |
| Edison Nation, Inc. | — | Manufacturing | Series C | $54.5M | $461.4M | 2022 |
| Document Security Systems Inc | — | Other Technology | Seed | $8.9M | $93.7M | 2009 |
| Profile Technologies Inc | — | Other | Seed | $6.3M | $2.2M | 2009 |
| MOAT BIOTECHNOLOGY Corp | — | Biotechnology | Seed | $1.6M | $1.1M | 2022 |
Philip Jones at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Philip Jones on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Todd Foley | 2 | 12 |
| Russell Rother | 2 | 3 |
| Richard Alvarez | 2 | 3 |
| Scott Rollins | 2 | 2 |
| David Klein | 1 | 10 |
| John Cronin | 1 | 8 |
| Tom Walker | 1 | 7 |
| William Paiva | 1 | 6 |
| Thomas Evans | 1 | 5 |
| Patrick White | 1 | 3 |
| Ira Greenstein | 1 | 3 |
| Scott Rollins, Ph.D. | 1 | 2 |
| Robert Fagenson | 1 | 2 |
| Rodger McEver, M.D. | 1 | 2 |
| Roger O'Brien | 1 | 2 |
| David Keiser | 1 | 2 |
| Richard Palmer | 1 | 2 |
| Philip Jones, M.D. | 1 | 2 |
| Ira A. Greenstein | 1 | 2 |
| David Falconer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.